{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T16:07:05Z","timestamp":1779811625770,"version":"3.53.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"DOI":"10.7759\/cureus.109683","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:57:36Z","timestamp":1779811056000},"source":"Crossref","is-referenced-by-count":0,"title":["Phenotypic Detection Methods, Clinical Outcomes, and Therapeutic Strategies for OXA-Type Carbapenemase-Producing Acinetobacter Species in an Indian Tertiary Care Setting"],"prefix":"10.7759","author":[{"given":"Pranay R","family":"Ullengala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra V","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish R","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.31018\/jans.v15i3.4872","article-title":"Acinetobacter baumannii producing ESBLs and carbapenemases in the Intensive Care Units developing fosfomycin and colistin resistance","volume":"15","author":"Abdulateef","year":"2023","unstructured":"Abdulateef, Al-Salmani, Aal Owaif. Acinetobacter baumannii producing ESBLs and carbapenemases in the Intensive Care Units developing fosfomycin and colistin resistance. J Appl Nat Sci. 2023, 15:1263-7. 10.31018\/jans.v15i3.4872","journal-title":"J Appl Nat Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2023.2289769","article-title":"Pathogenicity and virulence of Acinetobacter baumannii: Factors contributing to the fitness in healthcare settings and the infected host","volume":"15","author":"Lucidi M","year":"2024","unstructured":"Lucidi M, Visaggio D, Migliaccio A, Capecchi G, Visca P, Imperi F, Zarrilli R. Pathogenicity and virulence of Acinetobacter baumannii: Factors contributing to the fitness in healthcare settings and the infected host. Virulence. 2024, 15:2289769. 10.1080\/21505594.2023.2289769","journal-title":"Virulence"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki425","article-title":"OXA (beta)-lactamases in Acinetobacter: the story so far","volume":"57","author":"Brown S","year":"2006","unstructured":"Brown S, Amyes S. OXA (beta)-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother. 2006, 57:1-3. 10.1093\/jac\/dki425","journal-title":"J Antimicrob Chemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii: emergence of a successful pathogen","volume":"21","author":"Peleg AY","year":"2008","unstructured":"Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008, 21:538-82. 10.1128\/CMR.00058-07","journal-title":"Clin Microbiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417527","article-title":"The Dynamics of OXA-23 \u03b2-Lactamase from Acinetobacter baumannii","volume":"24","author":"Arrigoni R","year":"2023","unstructured":"Arrigoni R, Ballini A, Santacroce L, Palese LL. The Dynamics of OXA-23 \u03b2-Lactamase from Acinetobacter baumannii. Int J Mol Sci. 2023, 24:10.3390\/ijms242417527","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.18231\/j.joapr.2023.11.3.29.35","article-title":"Phenotypic methods for detection of metallo-\u03b2-lactamase (MBL) production in multidrug resistant gram negative bacilli - comparative study","volume":"11","author":"Hassani US","year":"2023","unstructured":"Hassani US, Mahalle R. Phenotypic methods for detection of metallo-\u03b2-lactamase (MBL) production in multidrug resistant gram negative bacilli - comparative study. J Appl Pharm Res. 2023, 11:29-35.","journal-title":"J Appl Pharm Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v2.i12.787","article-title":"Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside","volume":"2","author":"Lin MF","year":"2014","unstructured":"Lin MF, Lan CY. Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside. World J Clin Cases. 2014, 2:787-814. 10.12998\/wjcc.v2.i12.787","journal-title":"World J Clin Cases"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaf134","article-title":"The global epidemiology of carbapenem-resistant Acinetobacter baumannii","volume":"7","author":"Boutzoukas A","year":"2025","unstructured":"Boutzoukas A, Doi Y. The global epidemiology of carbapenem-resistant Acinetobacter baumannii. JAC Antimicrob Resist. 2025, 7:dlaf134. 10.1093\/jacamr\/dlaf134","journal-title":"JAC Antimicrob Resist"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fbrio.2025.1734537","article-title":"Acinetobacter baumannii: challenges presented by a drug-resistant pathogen","volume":"4","author":"Goncalves EK","year":"2026","unstructured":"Goncalves EK, Ramos LA, Seibert, et al.. Acinetobacter baumannii: challenges presented by a drug-resistant pathogen. Frontiers. 2026, 4:1-7. 10.3389\/fbrio.2025.1734537","journal-title":"Frontiers"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9030119","article-title":"Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen","volume":"9","author":"Ayoub Moubareck C","year":"2020","unstructured":"Ayoub Moubareck C, Hammoudi Halat D. Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen. Antibiotics (Basel). 2020, 9:10.3390\/antibiotics9030119","journal-title":"Antibiotics (Basel)"},{"key":"ref11","article-title":"Prevalence and antibiogram of Acinetobacter species isolated from various clinical samples in a Tertiary Care Hospital, Haryana, India","volume":"20","author":"Pushkar","year":"2022","unstructured":"Pushkar, Aashana, Jain P, Sharma M, Yadav A. Prevalence and antibiogram of Acinetobacter species isolated from various clinical samples in a Tertiary Care Hospital, Haryana, India. NeuroQuantology . 2022, 20:1720-8.","journal-title":"NeuroQuantology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.12510344","article-title":"Prevalence and antibiotic susceptibility profile of Acinetobacter species isolated from urinary tract infection at tertiary care hospital, Gujarat","volume":"15","author":"Pipaliya BP","year":"2023","unstructured":"Pipaliya BP, Dabhi CS, Soni ST, Shah PK, Vegad MM. Prevalence and antibiotic susceptibility profile of Acinetobacter species isolated from urinary tract infection at tertiary care hospital, Gujarat. Int J Pharm Clin Res. 2023, 15:1360-8. 10.5281\/zenodo.12510344","journal-title":"Int J Pharm Clin Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-023-01343-8","article-title":"Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon","volume":"12","author":"Itani R","year":"2023","unstructured":"Itani R, Khojah HM, Karout S, et al.. Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon. Antimicrob Resist Infect Control. 2023, 12:136. 10.1186\/s13756-023-01343-8","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S548066","article-title":"Successful treatment of OXA-23 Acinetobacter baumannii pneumonia with sulbactam-durlobactam in a liver transplant recipient","volume":"18","author":"Yin G","year":"2025","unstructured":"Yin G, Liu Z, Fu Z, Zhong Z, Ye S, Pan H. Successful treatment of OXA-23 Acinetobacter baumannii pneumonia with sulbactam-durlobactam in a liver transplant recipient. Infect Drug Resist. 2025, 18:5343-9. 10.2147\/IDR.S548066","journal-title":"Infect Drug Resist"},{"key":"ref15","article-title":"A study of prevalence and antimicrobial resistance of Acinetobacter species in a tertiary care hospital, Chidambaram, India","volume":"10","author":"Sunitha","year":"2022","unstructured":"Sunitha, Shanthi G, Sivaranjani A. A study of prevalence and antimicrobial resistance of Acinetobacter species in a tertiary care hospital, Chidambaram, India. Int J Allied Med Sci Clin Res. 2022, 10:442-8.","journal-title":"Int J Allied Med Sci Clin Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00042-16","article-title":"Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in south and southeast Asia","volume":"30","author":"Hsu LY","year":"2017","unstructured":"Hsu LY, Apisarnthanarak A, Khan E, Suwantarat N, Ghafur A, Tambyah PA. Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in south and southeast Asia. Clin Microbiol Rev. 2017, 30:1-22. 10.1128\/cmr.00042-16","journal-title":"Clin Microbiol Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209367","article-title":"A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit","volume":"13","author":"da Silva KE","year":"2018","unstructured":"da Silva KE, Maciel WG, Croda J, et al.. A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit. PLoS One. 2018, 13:e0209367. 10.1371\/journal.pone.0209367","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.22159\/ijcpr.2021v13i1.40803","article-title":"Prevalence and antibiotic susceptibility of Acinetobacter in a tertiary care hospital in Chennai, India","volume":"13","author":"Angeline Anjali A","year":"2020","unstructured":"Angeline Anjali A, Abiramasundari VK. Prevalence and antibiotic susceptibility of Acinetobacter in a tertiary care hospital in Chennai, India. Int J Curr Pharm Res. 2020, 13:35-40. 10.22159\/ijcpr.2021v13i1.40803","journal-title":"Int J Curr Pharm Res"},{"key":"ref19","article-title":"Prevalence of Acinetobacter species in various clinical samples and its antibiotic sensitivity pattern in tertiary care hospital, Vadodara","volume":"5","author":"Parmar AT","year":"2025","unstructured":"Parmar AT, Karia B, Mangukiya PD, Patel VA. Prevalence of Acinetobacter species in various clinical samples and its antibiotic sensitivity pattern in tertiary care hospital, Vadodara. GAIMS J Med Sci. 2025, 5:109-16.","journal-title":"GAIMS J Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.20546\/ijcmas.2021.1010.062","article-title":"Prevalence of ESBL and MBL producing Acinetobacter species isolated from various clinical samples in tertiary care hospital in north-west region of Rajasthan","volume":"10","author":"Kumari S","year":"2021","unstructured":"Kumari S, Pannu S, Gupta A, Tinna A, Sharma BP. Prevalence of ESBL and MBL producing Acinetobacter species isolated from various clinical samples in tertiary care hospital in north-west region of Rajasthan. Int J Curr Microbiol App Sci. 2021, 10:524-32. 10.20546\/ijcmas.2021.1010.062","journal-title":"Int J Curr Microbiol App Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.18502\/ijm.v14i2.9184","article-title":"Rapid identification of carbapenemases by CarbAcineto NP test and the rate of beta-lactamases among Acinetobacter baumannii from a teaching hospital","volume":"14","author":"Rao MR","year":"2022","unstructured":"Rao MR, Urs TA, Chitharagi VB, Shivappa S, Mahale RP, Gowda RS, Shree K. Rapid identification of carbapenemases by CarbAcineto NP test and the rate of beta-lactamases among Acinetobacter baumannii from a teaching hospital. Iran J Microbiol. 2022, 14:174-80. 10.18502\/ijm.v14i2.9184","journal-title":"Iran J Microbiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/ijabmr.ijabmr_498_24","article-title":"Genetic diversity of carbapenemases-producing Acinetobacter baumannii isolates at a tertiary teaching hospital in western India","volume":"15","author":"Datta A","year":"2025","unstructured":"Datta A, Gandham N, Vyawahare CR, Mirza S, Bhatia S, Shinde PB. Genetic diversity of carbapenemases-producing Acinetobacter baumannii isolates at a tertiary teaching hospital in western India. Int J Appl Basic Med Res. 2025, 15:91-7. 10.4103\/ijabmr.ijabmr_498_24","journal-title":"Int J Appl Basic Med Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485505-phenotypic-detection-methods-clinical-outcomes-and-therapeutic-strategies-for-oxa-type-carbapenemase-producing-acinetobacter-species-in-an-indian-tertiary-care-setting","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:57:37Z","timestamp":1779811057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485505-phenotypic-detection-methods-clinical-outcomes-and-therapeutic-strategies-for-oxa-type-carbapenemase-producing-acinetobacter-species-in-an-indian-tertiary-care-setting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.109683","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,26]]}}}